Drug Database
DI
didanosine (didanosine EC / Videx EC)
✓ ApprovedBristol-Myers Squibb · · Small Molecule
What is didanosine?
didanosine is a small molecule developed by Bristol-Myers Squibb. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | didanosine EC, Videx EC |
| Company | Bristol-Myers Squibb |
| Drug Class | Small Molecule |
| Route | Oral (PO) |
| Status | Approved |
Sources: ClinicalTrials.gov, Bristol-Myers Squibb
Mechanism of Action
Molecular Targets
didanosine acts on 1 molecular target:
| gag-pol, HIV-1 (gag-pol) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
didanosine is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Infections and infestations | Acquired immunodeficiency syndrome | ✓ Approved |
Related Research Articles
Unable to load articles right now.